Nielsen, Lene Kongsgaard http://orcid.org/0000-0003-2083-3870
Schjesvold, Fredrik
Möller, Sören
Guldbrandsen, Nina
Hansson, Markus
Remes, Kari
Peceliunas, Valdas
Abildgaard, Niels
Gregersen, Henrik
King, Madeleine T.
Funding for this research was provided by:
University of Southern Denmark
Article History
Received: 10 August 2023
Accepted: 18 January 2024
First Online: 5 February 2024
Ethics approval and consent of participate
: The study was conducted in accordance with ethical principles of the Declaration of Helsinki. The study was approved by North Denmark Region Committee on Health Research Ethics (N-20,130,064), Danish Health and Medicines Authority (No. 2,013,092,582) and Danish Data Protection Agency (No. 2008-58-0028). The trial was approved in each participating country by the relevant ethics committees and drug agencies. EudraCT number 2013-003789-15 and ClinicalTrials.gov number NCT02572492. EORTC and FACT provided permission for use of the questionnaires.Every participant gave informed consent to participation in the trial before inclusion.
: Not required.
: All of the authors declare that they have no competing interests.